Program Schedule

SSI Prevention: Unresolved and Non-Traditional ApproachesóLatest Recommendations and Continued Challenges

Thursday, October 9, 2014: 2:00 PM-3:30 PM
Room: The Pennsylvania Convention Center: 103-ABC

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • understand the impact of compliance with SCIP measures on SSI prevention and review and interpret conflicting data pertaining to SCIP and SSI prevention
  • review different the data supporting approaches to SSI prevention involving non-systemic uses of antimicrobials including as ointment, powder and irrigation
  • review the data pertaining to SSI prevention processes listed as "no recommendation given" in latest HICPAC document and provide practical approaches to evaluating their appropriateness for your patients

Target Audience: Scientists, Researchers, Nurses, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, Infection preventionists, Hospital epidemiologists, Epidemiologists, Clinicians, Academicians

Tracks: Pediatric ID, Epidemiology and Infection Control, Adult ID

Moderators:  Keith Kaye, MD, MPH, FIDSA, FSHEA, Detroit Medical Center/ Wayne State University and Deverick Anderson, MD, MPH, Duke University Medical Center

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: No CPE credit is offered for this session.

ACPE Number:


K. Kaye, Sage: Grant Investigator, Research grant

D. Anderson, None

D. W. Bratzler, None

J. Solomkin, None

P. Dellinger, Merck, Baxter, Ortho-McNeil, Targanta, Schering-Plough, Astellas, Durata, Pfizer, Applied Medical, Rib-X, Affinium, and 3M: Consultant, Consulting fee
Tetraphase: Investigator, Research grant

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, All Rights Reserved.

Follow IDWeek